CRL:NYSE
チャールズ・リバー・ラボラトリーズ・インターナショナル
$166.94
arrow_upward
+1.89%(+3.10) 1 日
4月30日, 16:00:00 GMT-4 · USD
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoCRL の上位の分析情報を生成しています...
始値
$163.15
高値
$167.32
安値
$161.95
時価総額
82.13億
平均出来高
84.69万
取引量
48.67万
52 週高値
$228.88
52 週安値
$107.60
EPS
-$2.91
ベータ版
1.61
発行済株式数
4934.20万
従業員数
2万
ニュース記事
ウェブの情報から
Yahoo! Finance Canada
·
6 時間前
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Stock Titan
·
8 時間前
First commercial rat IVF service targets breeding bottlenecks
プロフィール
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
チャールズ・リバー・ラボラトリーズ・インターナショナル について